Patents by Inventor Purvi Shah

Purvi Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW HUMAN CATHEPSIN
    Publication number: 20030100095
    Abstract: The invention provides a new human cathepsin (LCAP) and polynucleotides which identify and encode LCAP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of LCAP.
    Type: Application
    Filed: March 7, 2000
    Publication date: May 29, 2003
    Inventors: Olga Bandman, Karl J Guegler, Neil C Corley, Purvi Shah
  • Polynucleotides encoding a human S100 protein
    Publication number: 20030096337
    Abstract: The invention provides two human S100 proteins designated individually as S100P1 and S100P2 and collectively as S100P, and polynucleotides which identify and encode S100P. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of S100P.
    Type: Application
    Filed: January 26, 2000
    Publication date: May 22, 2003
    Inventors: Jennifer L. Hillman, Olga Bandman, Neil C. Corley, Preeti Lal, Purvi Shah
  • Human lysyl hydroxylase-like protein
    Publication number: 20030087409
    Abstract: The invention provides a human lysyl hydroxylase-like protein (HLHLP) and polynucleotides which identify and encode HLHLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HLHLP.
    Type: Application
    Filed: September 4, 2002
    Publication date: May 8, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Purvi Shah, Preeti Lal, Neil C. Corley
  • Delta -6 desaturase homologs
    Publication number: 20030077747
    Abstract: The invention provides a human delta-6 desaturase homolog (D6DH) and polynucleotides which identify and encode D6DH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of D6DH.
    Type: Application
    Filed: September 30, 2002
    Publication date: April 24, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Karl J. Guegler, Neil C. Corley, Purvi Shah
  • Transducin beta-1 subunit
    Publication number: 20030049786
    Abstract: The invention provides a human transducin beta-1 subunit (TBS) and polynucleotides which identify and encode TBS. The invention also provides expression vectors, host cells, agonists, antibodies, and antagonists. The invention also provides methods for treating or preventing diseases associated with expression of TBS.
    Type: Application
    Filed: September 5, 2002
    Publication date: March 13, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Preeti Lal, Neil C. Corley, Purvi Shah
  • Extracellular matrix and cell adhesion molecules
    Publication number: 20030044913
    Abstract: The invention provides human extracellular matrix and cell adhesion molecules (XMAD) and polynucleotides which identify and encode XMAD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of XMAD.
    Type: Application
    Filed: June 10, 2002
    Publication date: March 6, 2003
    Inventors: Henry Yue, Yalda Azimzai, Y. Tom Tang, Chandra Arvizu, Mariah R. Baughn, Dyung Aina M. Lu, Purvi Shah, Preeti Lal, Janice Au-Young, Neil Burford
  • Cathepsin differentially expressed in lung cancer
    Publication number: 20030036102
    Abstract: The invention is a new human cathepsin (LCAP), the cDNAs that encode LCAP, and antibodies that specifically bind LCAP that are used in methods for diagnosing and treating disorders of cell proliferation, particularly lung cancer, as associated with expression of LCAP. The invention provides expression vectors, host cells, and methods for making LCAP and agonists, antibodies and antagonists that specifically bind the protein.
    Type: Application
    Filed: May 8, 2002
    Publication date: February 20, 2003
    Inventors: Olga Bandman, Purvi Shah, Paula K. Rickert
  • Human hydrolase-like molecules
    Patent number: 6518029
    Abstract: The invention provides human hydrolase-like molecules (HHLM) and polynucleotides which identify and encode HHLM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HHLM.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: February 11, 2003
    Assignee: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Preeti Lal, Jennifer L. Hillman, Neil C. Corley, Karl J. Guegler, Purvi Shah
  • Human fatty acid beta-oxidation enzymes
    Patent number: 6511833
    Abstract: The invention provides human fatty acid beta-oxidation enzymes (HUFA) and polynucleotides which identify and encode HUFA. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HUFA.
    Type: Grant
    Filed: January 11, 2000
    Date of Patent: January 28, 2003
    Assignee: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Jennifer L. Hillman, Karl J. Guegler, Neil C. Corley, Y. Tom Tang, Purvi Shah
  • Human aflatoxin B1 aldehyde reductase
    Publication number: 20030013853
    Abstract: The invention provides a human aflatoxin B1 aldehyde reductase (AFB1-hAR) and polynucleotides which identify and encode AFB1-hAR. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of AFB1-hAR.
    Type: Application
    Filed: May 16, 2000
    Publication date: January 16, 2003
    Inventors: Olga Bandman, Purvi Shah, Karl J. Guegler, Neil C. Corley
  • Human glutathione-S-transferase
    Patent number: 6506571
    Abstract: The invention provides a human glutathione-S-transferase (HGST) and polynucleotides which identify and encode HGST. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of HGST.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: January 14, 2003
    Assignee: Incyte Genomics, Inc.
    Inventors: Henry Yue, Neil C. Corley, Purvi Shah
  • Delta-6 desaturase homologs
    Patent number: 6492108
    Abstract: The invention provides a human delta-6 desaturase homolog (D6DH) and polynucleotides which identify and encode D6DH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of D6DH.
    Type: Grant
    Filed: March 26, 1998
    Date of Patent: December 10, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Karl J. Guegler, Neil C. Corley, Purvi Shah
  • Human lysyl hydroxylase-like protein
    Patent number: 6489444
    Abstract: The invention provides a human lysyl hydroxylase-like protein (HLHLP) and polynucleotides which identify and encode HLHLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HLHLP.
    Type: Grant
    Filed: June 13, 2000
    Date of Patent: December 3, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Purvi Shah, Preeti Lal, Neil C. Corley
  • Human phospholipase A2 protein
    Publication number: 20020177208
    Abstract: The invention provides a human phospholipase A2 protein PHPLA2 and polynucleotides which identify and encode PHPLA2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of PHPLA2.
    Type: Application
    Filed: April 16, 2002
    Publication date: November 28, 2002
    Applicant: Incyte Genomics, Inc.
    Inventors: Phillip R. Hawkins, Olga Bandman, Karl J. Guegler, Purvi Shah, Neil C. Corley
  • Human retinoid binding protein
    Publication number: 20020173002
    Abstract: The invention provides a human retinoid binding protein (RBPhu) and polynucleotides which identify and encode RBPhu. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of RBPhu.
    Type: Application
    Filed: December 21, 2001
    Publication date: November 21, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Karl J. Guegler, Purvi Shah
  • Transducin beta-1 subunit
    Patent number: 6465619
    Abstract: The invention provides a human transducin beta-1 subunit (TBS) and polynucleotides which identify and encode TBS. The invention also provides expression vectors, host cells, agonists, antibodies, and antagonists. The invention also provides methods for treating or preventing diseases associated with expression of TBS.
    Type: Grant
    Filed: January 21, 2000
    Date of Patent: October 15, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Preeti Lal, Neil C. Corley, Purvi Shah
  • New annexin binding protein
    Publication number: 20020127225
    Abstract: The invention provides a human annexin binding protein (NABP-1) and polynucleotides which identify and encode NABP-1. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of NABP-1.
    Type: Application
    Filed: March 14, 2001
    Publication date: September 12, 2002
    Applicant: Incyte Pharmaceuticals, Inc
    Inventors: Jennifer L. Hillman, Neil C. Corley, Purvi Shah
  • Phosphatidylinositol 4,5-bisphosphate 5-phosphatase
    Publication number: 20020127217
    Abstract: The invention provides a human phosphatidylinositol 4,5-bisphosphate 5-phosphatase (PBPP) and polynucleotides which identify and encode PBPP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of PBPP.
    Type: Application
    Filed: June 26, 2001
    Publication date: September 12, 2002
    Applicant: Incyte Pharmaceuticals, Inc
    Inventors: Jennifer L. Hillman, Preeti Lal, Neil C. Corley, Purvi Shah
  • Ndr2-related proteins
    Patent number: 6444430
    Abstract: The invention provides cDNA which encode Ndr2-related proteins. It also provides for the use of the cDNAs, fragments, complements, and variants thereof and of the encoded proteins, portions thereof and antibodies thereto for diagnosis and treatment of cancer, particularly cancers of the intestine, breast, uterus, liver, brain, and kidney. The invention additionally provides expression vectors and host cells for the production of the proteins and a transgenic model system.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: September 3, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Susan G. Stuart, Janice Au-Young, Jennifer L. Hillman, Purvi Shah, Henry Yue
  • Interferon-responsive protein
    Publication number: 20020103339
    Abstract: The invention provides human ISRE-binding protein (HIBP) and polynucleotides which identify and encode HIBP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HIBP.
    Type: Application
    Filed: September 5, 2001
    Publication date: August 1, 2002
    Applicant: Incyte pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Preeti Lal, Neil C. Corley, Karl J. Guegler, Chandra Patterson, Mariah R. Baughn, Susan K. Sather, Purvi Shah